| |
| |
|
| Insider
Information: |
Mcdevitt Damien |
| Relationship: |
Chief Executive Office... |
| City: |
Carlsbad |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
2,573 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$105,313 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
2,573 |
|
|
| Total
Value |
$105,313 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
1
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
1.0
|
| Percentage
Gain/Loss : |
0.0%
|
 50.5%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Ionis Pharmaceuticals Inc |
IONS |
Chief Business Officer |
2019-07-15 |
2,573 |
|
0 |
Premium* |
|
|
Akcea Therapeutics Inc |
AKCA |
Chief Executive Office... |
2020-10-12 |
0 |
2019-09-19 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
10 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| AKCA |
Akcea Therapeutics Inc |
Chief Executive Officer |
• • – |
2020-10-12 |
4 |
D |
$18.15 |
$4,410,051 |
D/D |
(242,978) |
0 |
0 |
- |
|
| AKCA |
Akcea Therapeutics Inc |
Chief Executive Officer |
• • – |
2020-09-22 |
4 |
S |
$18.12 |
$157,807 |
D/D |
(8,709) |
242,978 |
0 |
- |
|
| AKCA |
Akcea Therapeutics Inc |
Chief Executive Officer |
• • – |
2020-08-31 |
4 |
A |
$14.40 |
$15,896 |
D/D |
1,104 |
251,687 |
0 |
- |
|
| AKCA |
Akcea Therapeutics Inc |
Chief Executive Officer |
• • – |
2020-03-23 |
4 |
S |
$11.75 |
$110,649 |
D/D |
(9,417) |
245,783 |
0 |
% |
|
| AKCA |
Akcea Therapeutics Inc |
Chief Executive Officer |
• • – |
2020-03-19 |
4 |
A |
$0.00 |
$0 |
D/D |
55,200 |
255,200 |
0 |
- |
|
| AKCA |
Akcea Therapeutics Inc |
Chief Executive Officer |
• • – |
2020-03-19 |
4/A |
A |
$0.00 |
$0 |
D/D |
60,000 |
260,000 |
0 |
- |
|
| AKCA |
Akcea Therapeutics Inc |
Interim Chief Executive Office |
• • – |
2019-09-19 |
4 |
A |
$0.00 |
$0 |
D/D |
200,000 |
200,000 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chief Business Officer |
• – – |
2019-07-15 |
4 |
D |
$67.86 |
$83,129 |
D/D |
(1,225) |
2,573 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chief Business Officer |
• – – |
2019-07-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,542 |
3,798 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chief Business Officer |
• – – |
2019-07-01 |
4 |
A |
$45.70 |
$11,700 |
D/D |
256 |
256 |
0 |
- |
|
10 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
